Search Results 1671-1680 of 19009 for Ophthalmic

  1. Choosing the optimal approach for giant pituitary adenomas - Mayo Clinic

    Endocrinology. Neurologic Surgery. Head and Neck Surgery. Rhinology and Sinus Surgery. Neuro-ophthalmology. Neuroradiology. Radiation Oncology. Mayo ...

  2. Faculty - Biomedical Engineering and Physiology - Tracks - Ph.D. Program - Biomedical Research Training - Mayo Clinic College of Medicine & Science

    Raymond Iezzi, Jr., M.D.. Associate Professor of Ophthalmology. Iezzi.Raymond@mayo.edu. Show more View full profile Opens in new tab.

  3. Nayantara Coelho-Prabhu, M.B.B.S. - Doctors and Medical Staff - Mayo Clinic

    2001. Final Year Ophthalmology M.B.B.S.. Examination, Distinction, October 2001.University of Mumbai. Show more awards and honors. Professional memberships.

  4. Meet The Faculty - Otolaryngology - Head and Neck Surgery Residency (Minnesota) - Mayo Clinic College of Medicine & Science

    General otorhinolaryngology; Sleep surgery. Department members collaborate with other specialists in audiology, speech and swallowing therapy, ophthalmology, ...

  5. Mayo Clinic remembers Dr. Michael O'Sullivan, former member of Board of Governors, pioneering leader

    Dr. Michael O'Sullivan, a former member of the Mayo Clinic Board of Governors and CEO of Mayo Clinic in Arizona, passed away on April 20.

  6. A Study to Evaluate Effectiveness and Safety of MBG453 in Combination with Azacitidine in Subjects With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS), or Chronic Myelomonocytic Leukemia-2 (CMML-2) - Mayo Clinic

    Topical, inhaled, nasal, ophthalmic steroids are allowed. Replacement therapy, steroids given in the context of a transfusion are allowed and not considered ...

  7. A Study of the Combination of IMCgp100 with Durvalumab and/or Tremelimumab for Patients with Advanced Cutaneous Melanoma - Mayo Clinic

    Local steroid therapies (eg, otic, ophthalmic, intra-articular or inhaled medications) are acceptable. Use of any live vaccines against infectious diseases ...

  8. Deucravacitinib (BMS-986165) in LPP and FFA - Mayo Clinic

    Have a history of disseminated/complicated herpes zoster (for example, ophthalmic zoster or CNS involvement). ALT or AST > 2 x upper limits of normal (ULN); ...

  9. Dry macular degeneration - Doctors and departments - Mayo Clinic

    Ophthalmology · Vitreoretinal Diseases and Surgery Clinic. Research. Mayo Clinic ... Read more about what's happening in ophthalmology research at Mayo Clinic.

  10. Dry macular degeneration - Doctors and departments - Mayo Clinic

    Ophthalmology · Vitreoretinal Diseases and Surgery Clinic. Research. Mayo Clinic ... Read more about what's happening in ophthalmology research at Mayo Clinic.